Volume 3, #1, May 1997
State-of-the-Art in the Management of Cancer
Ovarian Cancer-PART III Current Treatment Approaches

Cytoreductive Surgery

Second Look Surgical Reassessment

Prophylactic Oophorectomy

Radiation Therapy

Chemotherapy

Primary Disease

• Single-agent chemotherapy
• Combination chemotherapy

Drug Resistance

Recurrent/Refractory Disease

Dose-Intensive Chemotherapy with Bone Marrow and/or Peripheral Stem Cell Transplants

Drug Administration Routes

• Intra-arterial chemotherapy
• Intraperitoneal chemotherapy

Meeting Coverage

New Testing Approaches for human papillomavirus

From the 45th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists

Las Vegas, NV, April 28-30, 1997

Screening and Diagnosis of Cervical Cancer

Role of Human Papillomavirus in Cervical Cancer

• Digene’s Hybrid Capture HPV DNA Assay

Diagnostic Triage Using HPV Screening

New Developments in the Treatment of Gynecologic Cancers

From the 21st Congress of the European Society of Medical Oncology, Vienna, Austria; November 1-5, 1996

Invasive Cervical Cancer

Metastatic Cervical Cancer

• HIV-related invasive cervical cancer

Combination Regimens in Invasive Cervical Cancer

• Combination of cisplatin and vinorelbine
• Combination of cisplatin and paclitaxel

Ovarian Cancer

Gemcitabine in Advanced Epithelial Ovarian Cancer (EOC)

Topotecan in Recurrent EOC

Marimastat for Advanced EOC

Paclitaxel and Ifosfamide in Advanced EOC

Primary Fallopian Tube Carcinoma